Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biolen CP-001
- Development stage
- Unknown
- Lead developer
- Alessa Therapeutics
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules
- Administration
- Implant
01
Overview
Biolen CP-001 is an investigational localized therapy developed by RegCell for the treatment of prostate cancer, specifically in the pre-prostatectomy setting. The treatment utilizes a biodegradable seed implant (Biolen) to provide sustained release of an androgen receptor (AR) antagonist directly into the prostate tissue. By targeting the androgen receptor, which is the primary driver of prostate cancer growth, Biolen CP-001 aims to achieve high local drug concentrations to reduce tumor size and improve surgical outcomes. This localized approach is intended to offer the efficacy of androgen deprivation therapy (ADT) while avoiding the systemic toxicities associated with oral AR antagonists. The program is currently in Phase 1 clinical development.
- Brand names
- Biolen
- Other names
- Biolen
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on Biolen CP-001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biolen CP-001.